Increased MDR1 P-glycoprotein expression in methotrexate resistance: comment on the article by Yudoh et al.
Rahman
P
P
Hefferton
D
D
Robb
D
D
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism*; D003545:Cysteine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004347:Drug Interactions; D018432:Drug Resistance, Multiple; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000627:therapeutic use; D018417:Th1 Cells / Q000378:metabolism*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018501:Antirheumatic Agents; D012460:Sulfasalazine; D003545:Cysteine; C026535:bucillamine; D008727:Methotrexate